Clinical effect of intermittent oro-esophageal tube feeding combined with Xuanqiaoliyan decotion in patients with dysphagia after stroke

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046004

Enrollment

Unknown

Registered

2021-05-02

Start date

2018-01-01

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

experimental group:intermittent oro-esophageal tube feeding (IOE) combined with Xuanqiaoliyan decotion

control group:intermittent oro-esophageal tube feeding (IOE)

Eligibility

Sex/Gender

All

Age

47 Years to 71 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic criteria of stroke in Chinese guidelines for the prevention and treatment of cerebrovascular diseases; 2. Dysphagia was confirmed by clinical standard swallowing assessment (SSA) and Wadian drinking water test; 3. The patient's condition is stable and conscious, and can cooperate with IOE operation independently and tolerate the treatment of traditional Chinese medicine; 4. Patients with complete clinical data voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with esophageal tumor and other cardiovascular and cerebrovascular diseases; 2. Autoimmune dysfunction, liver and kidney dysfunction; 3. Patients with mental illness; 4. The patients who did not tolerate the treatment used in this study.

Design outcomes

Primary

Measure	Time frame
standardized swallowing assessment, SSA;	—

Countries

China

Contacts

Public ContactPanel Haiying

Yidu Central Hospital Affiliated Hospital of Weifang Medical University

515503151@qq.com+86 13780803296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026